GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ectin Research AB (XSAT:ECTIN B) » Definitions » Equity-to-Asset

Ectin Research AB (XSAT:ECTIN B) Equity-to-Asset : 0.43 (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Ectin Research AB Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Ectin Research AB's Total Stockholders Equity for the quarter that ended in Mar. 2024 was kr1.90 Mil. Ectin Research AB's Total Assets for the quarter that ended in Mar. 2024 was kr4.42 Mil.

The historical rank and industry rank for Ectin Research AB's Equity-to-Asset or its related term are showing as below:

XSAT:ECTIN B' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.43   Med: 0.89   Max: 0.96
Current: 0.43

During the past 4 years, the highest Equity to Asset Ratio of Ectin Research AB was 0.96. The lowest was 0.43. And the median was 0.89.

XSAT:ECTIN B's Equity-to-Asset is ranked worse than
68.91% of 1557 companies
in the Biotechnology industry
Industry Median: 0.67 vs XSAT:ECTIN B: 0.43

Ectin Research AB Equity-to-Asset Historical Data

The historical data trend for Ectin Research AB's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ectin Research AB Equity-to-Asset Chart

Ectin Research AB Annual Data
Trend Aug19 Aug20 Dec22 Dec23
Equity-to-Asset
0.92 0.89 0.90 0.65

Ectin Research AB Quarterly Data
Aug19 Aug20 Mar21 Sep21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.89 0.91 0.88 0.65 0.43

Competitive Comparison of Ectin Research AB's Equity-to-Asset

For the Biotechnology subindustry, Ectin Research AB's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ectin Research AB's Equity-to-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ectin Research AB's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Ectin Research AB's Equity-to-Asset falls into.



Ectin Research AB Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Ectin Research AB's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Equity to Asset (A: Dec. 2023 )=Total Stockholders Equity/Total Assets
=4.199/6.428
=

Ectin Research AB's Equity to Asset Ratio for the quarter that ended in Mar. 2024 is calculated as

Equity to Asset (Q: Mar. 2024 )=Total Stockholders Equity/Total Assets
=1.9/4.418
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ectin Research AB  (XSAT:ECTIN B) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Ectin Research AB Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Ectin Research AB's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Ectin Research AB (XSAT:ECTIN B) Business Description

Traded in Other Exchanges
N/A
Address
Pepparedsleden 1, Molndal, SWE, 431 83
Ectin Research AB is a pharmaceutical company developing a novel treatment that eliminates cancer tumors. Its drug candidate MFA-370 engages in the treatment of metastatic bladder cancer, and has also shown potential in other cancers such as breast, colorectal and prostate cancer cells.

Ectin Research AB (XSAT:ECTIN B) Headlines

No Headlines